Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07282587 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

Name: Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma — clinical trial record (NCT07282587)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorJazz Pharmaceuticals

Started2026-01-02

View on ClinicalTrials.gov ↗

Amendment history

2026-06-09

Study Status, Contacts/Locations v2

Study sitesdetails revised at 2 of 9 sites

2026-02-24

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Start dateestimated 2025-12-15→confirmed 2026-01-02

Study sites10→9

2025-12-05

Original filing

Jazz Pharmaceuticals

34 trials monitored

See 1 trial at risk

This is a two-stage Phase 2 trial evaluating the efficacy and safety of ONC206 in participants with Pheochromocytoma and Paraganglioma (PCPG).

Trial Details

NCT Number	NCT07282587
Lead Sponsor	Jazz Pharmaceuticals
Conditions	Advanced Pheochromocytoma and Paraganglioma, PCPG
Enrollment	90 participants
Start Date	2026-01-02
Primary Completion	2028-12-15 (estimated)
Study Completion	2028-12-15 (estimated)
Updated on ClinicalTrials.gov	2026-06-10